Phlecs initiates the development project of a new generation of phototherapy blue light – UV free medical device: the Full Body Home Connected.
Characterization of Blue Light Treatment for Infected Wounds: Antibacterial Efficacy of 420, 455, and 480 nm Light-Emitting Diode Arrays Against Common Skin Pathogens Versus Blue Light-Induced Skin Cell Toxicity
BL treatment can be effective against bacterial infections of chronic wounds. View abstract
Blue photobiomodulation LED therapy impacts SARS‐CoV‐2 by limiting its replication in Vero cells
Blue light even at longer wavelengths shows antifibrotic activity and may represent a suitable and safe approach in the tvitro findings could represent the starting point for translational applications of PBMT as a supportive approach to fight SARS‐CoV‐2 ...
Prospective 3-month study on the efficacy of UV-free blue light in mild psoriasis vulgaris treatment
These results confirm that phototherapy using blue LED light is both a safe and highly effective way to treat psoriasis. View abstract
Blue Light Therapy clinical investigations in Poland
Interview of Professor Lesiak at the Polish national television – May 2021
English subtitles available
The power of Blue Light – phototherapy for recovering from COVID-19
AGATA RUCIŃSKA APRIL 12, 2021 Blue light, emitted by LED lamps, is one of the phototherapy methods that has been recently enjoying great popularity, mainly in dermatology, but not only. Prof. Joanna Narbutt, Prof. Aleksandra Lesiak and Dr. n. med ...
NEW STUDY ON BLUE LIGHT: The impact of non-toxic blue light (453 nm) on cellular antioxidative capacity, TGF-β1 signaling, and myofibrogenesis of human skin fibroblasts
Blue light even at longer wavelengths shows antifibrotic activity and may represent a suitable and safe approach in the treatment of fibrotic skin diseases including hypertrophic scarring and scleroderma. Link to abstract
The impact of non-toxic blue light (453 nm) on cellular antioxidative capacity, TGF-β1 signaling, and myofibrogenesis of human skin fibroblasts
Blue light even at longer wavelengths shows antifibrotic activity and may represent a suitable and safe approach in the treatment of fibrotic skin diseases including hypertrophic scarring and scleroderma. View abstract
PHLECS winner of the EIT Health’s Bridgehead Global program 2020
Dutch MedTech start-up PHLECS has just been selected by EIT Health to participate in its Bridgehead Global program. After receiving the CE marking for its Full Body Blue Light device last March, PHLECS is now moving forward to its next business milestone ...
PHLECS, a Dutch start-up that launches a new drug-free therapy for psoriasis
The Dutch MedTech start-up has just obtained the medical CE marking for the Full Body Blue Light Device and will start its commercialization in Europe from April 2020 onwards. Press release